Approved Study Database
Ref. No. | Scientific Title | Principal investigator |
---|---|---|
2007.308 | Multi-Dose Study to Investigate Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles of DU-176b in Chinese Healthy Male Adult Subjects | Prof. Briant Tomlinson |
2007.307 | A Phase 2, Randomized, Parallel Group, Multi-Center, Multi-National Study for the Evaluation of Safety and Efficacy of Two Fixed Dosages of DU-176b in Subjects with Non-Valvular Atrial Fibrillation | Prof. Yu Cheuk Man |
2007.304 | The Effectiveness of a Structured Home Blood Pressure Monitoring Programme at Primary Care: A Cluster Randomized Controlled Trial | Prof. Fung Siu Cheung Colman |
2007.301 | Augmentation for Healing of Acute Clavicular Fracture with LIPUS | Dr. Lam Tsz Ping |
2007.300 | A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients with Severe Sepsis | Prof. Charles David GOMERSALL |
2007.292 | A Randomized, Double-Blind, Pilot Study Comparing the Saftey and Efficacy of Betamare Plus Chemotherapy to Chemotherapy Alone in the Prevention and Treatment of Cancer Anorexia and Cachexia in Patients with Advanced Non-Small Cell Lung Cancer | Dr. Lam Kwok Chi |
2007.288 | Use of Niacin for Erectile Dysfunction in Patients with Concomitant Hyperlipidaemia | Dr. Lee Chui Ping |
2007.284 | Chronic Disease Self-Management Program (CDSMP) For Care of Older Persons: A Controlled Trial | Prof. Hui Elsie |
2007.282 | A Multicenter, Randomized, Double-Blind, | Prof. Yu Cheuk Man |
2007.281 | A Comparative Pharmacokinetic Study of Cilostazol SR Capsule with Pletaal Tablet in Healthy Male Subjects | Prof. Brian Tomlinson |
2007.278 | Clinical Bioequivalence Study on Two Diazepam Formulations | Prof. Lee HL Vincent |
2007.277 | Dose Escalation Trial of Traditional Chinese Medicine for Irritable Bowel Syndrome (TCM-IBS) | Prof. Chan K.L. Francis |
2007.273 | A Multicenter, Double-Blind, Randomized, Placebo and Active Comparator Controlled Dose-Range Finding Study of MK-0893 in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control | Dr. Ma Ronald |
2007.272 | A Phase IIa Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-0773 in Patients with Sarcopenia | Prof. Woo Jean |
2007.271 | A Multicenter, Randomized, Double-Blind, | Prof. Brian Tomlinson |
2007.268 | Efficacy and Safety of 2mg/day of M100907 on Sleep Maintenance Insomnia with a Sub-study of the Effect of M100907 on Stable Type II Diabetes Mellitus: A One Year, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study | Prof. Wing Yun Kwok |
2007.267 | Prospective Trial of a Herbal Formula BYSH and Saw Palmetto in Patients with Hormonal Refractory Prostate Cancer | Prof. Ng Chi Fai |
2007.261 | The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuria | Prof. Szeto Cheuk Chun |
2007.251 | Self Expandable Metal Stent (SEMS) Against Combined Brachytherapy and External Radiotherapy for Palliation of Advanced Oesophageal Cancer | Prof. Chiu Wai Yan Philip |
2007.249 | Multi-Center, Double-blind, Randomized, Placebo-Controlled, Dose Ranging Phase 2 Study to Investigate Efficacy, Safety, Tolerability and Pharmacokinetics of the DPP-IV Inhibitor RO4876904 in Patients with Type 2 Diabetes | Prof. Kong P.S. Alice |
2007.248 | An International, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Flexible Dose Study: Evaluation of the Safety and Efficacy of Brivaracetam in Subjects (> 16 to 70 years old) Suffering From Localization-Related or Generalized Epilepsy | Dr. Kwan Patrick |
2007.247 | An Open-Label Multicenter Study Administering Lapatinib and Capecitabine (Xeloda) in Women with Advanced or Metastatic Breast Cancer | Prof. Yeo Winnie |
2007.246 | A Double-Blind, Randomized, Placebo-Controlled Phase III Study to Assess the Efficacy of recMAGE-A3 + AS15 Antigen Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients with Resectable MAGE-A3-Positive Non-Small Cell Lung Cancer | Prof. MOK Tony SK |
2007.245 | Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging Phase 2 Study to Investigate Efficacy, Safety, Tolerability and Pharmacokinetics of the DPP-IV Inhibitor RO4876904 in Patients with Type 2 Diabetes | Prof. Brian Tomlinson |
2007.244 | Clinical Bioequivalence Study on Two Acarbose Formulations | Prof. Brian Tomlinson |
2007.243 | 12-Week, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group, Multicenter Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine ER in Patients with Overactive Bladder | Prof. Ng Chi Fai |
2007.242 | An Open-Label Prospective Trial to Explore the Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Subjects with Schizophrenia | Dr. Chung Wai Sau Dicky |
2007.241 | An Open-Label Phase I/II Study to Assess the Safety and Immunogenicity of Two Doses of a Vero Cell-Derived, Whole Virus Clade 2 H5N1 Influenza Vaccine in Healthy Volunteers Aged 21 to 45 Years | Prof. Hui SC David |
2007.239 | Evaluation of the T-SPOT, TB and QuantiFERON-TB Gold Test in the Targeted Screening of Latent Tuberculosis Infection among Patients Receiving or Going to Receive Immunocompromised Patients in Hong Kong | Prof. Tam Lai Shan |
2007.231 | Evaluation of the Impact of Diabetes on the Quality of Life of Elderly Chinese People in Hong Kong | Ms. Tung Yuk Wah |
2007.230 | A Phase 2, Multicenter, Open Label, Randomized Trial of AMG 706 or Bevacizumab in Combination with Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer | Prof. Mok S.K. Tony |
2007.229 | A Multi-center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Na_ve Patients with HBeAg Negative Chronic Hepatitis due to Hepatitis B Virus | Prof. Chan LY Henry |
2007.228 | A Multi-center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Na_ve Patients with HBeAg Positive Chronic Hepatitis due to Hepatitis B Virus | Prof. Chan LY Henry |
2007.227 | A Multi-Center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Na_ve Patients with HBeAg Negative Chronic Hepatitis due to Hepatitis B Virus | Dr. Leung WY Nancy |
2007.226 | A Multi-Center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Na_ve Patients with HBeAg Positive Chronic Hepatitis due to Hepatitis B Virus | Dr. Leung WY Nancy |
2007.222 | Effects of Orlistat With or Without Strength Training on Physical Fitness and Endothelial Function of Obese Adolescents | Prof. Li Albert Martin |
2007.219 | A Pilot Study on Vibration Therapy for Osteopenia and Balance Control in Girls with Adolescent Idiopathic Scoliosis (AIS) | Prof. Cheng J.C.Y. |
2007.206 | A Comparative Study of Entecavir vs Adefovir plus Lamivudine vs Combination Entecavir plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Subjects: The DEFINE Study | Prof. Chan Lik Yuen Henry |
2007.201 | Comparison of Various Lodoz / Angiotensin Receptor Blocker Combination Regimens in the Treatment of Hypertension | Prof. TOMLINSON Brian |
2007.200 | An Open-Label, Randomized, Phase 2 Study of Efficacy and Tolerability of ABT-869 in Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | Prof. Mok S.K. Tony |
2007.199 | An Open-Label, Phase 2 Study of Efficacy and Tolerability of ABT-869 in Advanced Hepatocellular Carcinoma (HCC) | Prof. Yeo Winnie |
2007.198 | A Phase II Study of Concurrent Chemoradiotherapy Using Three-Dimensional Conformal Radiotherapy (3D-CRT) or Intensity-Modulated Radiation Therapy (IMRT) + Bevacizumab (BV) for Locally or Regionally Advanced Nasopharyngeal Cancer | Prof. CHAN Anthony T. C. |
2007.197 | A Multi-Centre, Randomized, Controlled Study of External CounterPulsation for Patients with Recent Atherosclerotic Stroke | Prof. WONG Lawrence Ka Sing |
2007.196 | Overcoming Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Management of Advanced Stage Non-Small Cell Lung Cancer | Prof. Mok Tony |
2007.195 | The Implementation and Evaluation of a Cognitive-Behavioral Randomized Controlled HIV Intervention Prevention Trial for at-Risk Monogamous Chinese Women Attending Public STD Clinics in Hong Kong | Prof. Lau T.F. Joseph |
2007.194 | Randomized Trial Comparing A Novel Physical Antimicrobial Dressing Aerosal (Jieyoushen) With Placebo in Prevention of Catheter Associated Urinary Tract Infection in Chinese Patients with Urethral Catheter Secondary to Acute Retention of Urine | Prof.. Ng Chi Fai |
2007.186 | A Phase 3, Randomized, Double-Blind, Parallel-Group, Multi-Center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely I11 Medical Subjects During and Following Hospitalization | Dr. Wong Siu Ming Raymond |
2007.185 | A Randomized, Crossover Study of Medroxyprogesterone Acetate and Diane-35 on Polycystic Ovarian Syndrome Adolescents | Dr. Chan Shing Chee Symphorosa |
2007.183 | A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Dose-Response Study of Rivoglitazone (CS-011) in Patients with Type 2 Diabetes | Prof. Kong P.S. Alice |
2007.180 | A Phase 3, Multi-Center, Randomized Double-Blind, Placebo-Controlled 52 Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B | Prof. Li Kwok Ming Edmund |
Page 238 of 254.